Human papillomavirus infection at the United States-Mexico border: Implications for cervical cancer prevention and control

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 11, 2001, Pages 1129-1136

  Giuliano, Anna R ^a   Papenfuss, Mary ^a   Abrahamsen, Martha ^a   De Zapien, Jill Guernsey ^a,b   Stephan, Jennifer ^a   Feng, Janine ^c   Baldwin, Susie ^b   Garcia, Francisco ^b   Hatch, Kenneth ^b   Denman, Catalina ^d   Henze, Jose Luis Navarro ^e   De Galaz, Elena Mendez Brown ^f   Ortega, Luis ^g  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d El Colegio de Sonora   (Mexico)

^e Servicios de Salud de Sonora   (Mexico)

^f Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado de Sonora (ISSSTESON)   (Mexico)

^g ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PREVENTION; CANCER RISK; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MEXICO; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SQUAMOUS CELL CARCINOMA; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MEXICO; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 0035161207     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Estimates of the world wide incidence of 25 major cancers in 1990
2. HPV international prevalence surveys in general populations
3. International biological study on cervical cancer study group. Prevalence of human papillomavims in cervical cancer: A worldwide perspective
4. Human papiliomavlrus is a necessary cause of invasive cervical cancer worldwide
5. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
6. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
7. A randomized, double-blind, placebo-controlled trial of the immunogenicity and reactogenicity of a novel HPV 16 vacine: Preliminary results
8. Human papillomavirus 16-18 infection and cervical cancer in Mexico: A case control study
9. Epidemiology of HPV infection among Mexican women with normal cervical cytology
10. HPV prevalence among Mexican women with neoplastic and normal cervixes
11. The problem of invasive cervical cancer along the US-Mexico border: Planning and implementation of a binational research project
12. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study
13. Improved amplification of genital human papillomaviruses
14. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
15. Risk factors for high risk type human papillomavirus infection among Mexican American women
16. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
17. Population-based study of human papilloma-virus infection and cervical neoplasia in rural Costa Rica
18. Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high risk area (Greenland) and a low risk area (Denmark)-a second look
19. Risk factors for cervical cancer in Colombia and Spain
20. Importance of human papillnmavirus endemicity in the incidence of cervical cancer: An extension of the hypothesis on sexual behavior
21. Human papillomavirus type 16 variants and risk of cervical cancer
22. Conversion of HPV 18 positive non-tumorogenic HeLa-fibroblast hybrids tn invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP- 1 transcription complex
23. The role of nutrients in the prevention of cervical cancer
24. Antioxidant nutrients: Associations with persistent human papillomavirus infection
25. Uterine cervical cancer risk in cigarette smokers: A meta-analytic study
26. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection
27. HPV 16 and cigarette smoking as risk factors for high grade cervical intraepithelial neoplasia
28. The histories of women with invasive cervical cancer, Connecticut
29. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: A case control study
30. Human papillomavirus infection and invasive cervical cancer in Paraguay
31. Human papillomavirus infection in Mexican women with cervical cancer, squamous intraepithelial lesion and cytologically normal
32. Persistence of type-specific human papillomavirus infection among cytologically normal women
33. Natural history of cervicovaginal papillomavirus infection in young women
34. Risk factors for HP DNA detection in middle aged women
35. Determinants of genital human Papillomavirus infection among cytologically normal women attending the University of New Mexico Student Health Center
36. Determinants of genital human papillomavirus infection in low-income women in Washington DC
37. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: Are there different risk profiles for oncogenic and no-oncogenic HPV types
38. Determinants of genital human papillomavirus infection in low risk women in Portland, OR. Sex
39. A cumulative case control study of risk factor profiles for oncogenic and non-oncongenic cervical human papillomavirus infections
40. Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain
41. Influence of ovarian hormones on urogenital infections
42. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins form oral contraceptives
43. Human papillomavirus type 16 cooperates with activated ras and los oncogenes in the hormone-dependent transformation of primary mouse cells
44. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone
45. Regulation of human papillomavirus type 18 in vivo: Effects of estrogen and progesterone in transgenic mice
46. The upstream regulatory region of the human papillomavirus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones
47. Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses
48. Chlamydia and cervical cancer: A real association?
49. Serotypes of Chlamydia trachomatis and risk of development of cervical squamous cell carcinoma